Effect of Roux-en-Y gastric bypass on the hepatic bile acids signaling and gluconeogenesis in type 2 diabetic rats
洪劲松,常诚,王百林,方少梅,苑伟,颜勇
DOI: https://doi.org/10.3760/cma.j.cn421213-20190319-00188
2021-01-01
Abstract:Objective:To investigate the effect of Roux-en-Y gastric bypass (RYGB) on the hepatic bile acids signaling and gluconeogenesis in type 2 diabetes mellitus (T2DM) rats.Methods:A total of 16 Sprague-Dawley male rats were fed on a high-fat diet and injected intraperitoneally with streptozotocin to induce T2DM, then all rats were randomly divided into sham surgery group ( n=8) and RYGB group ( n=8). RYGB surgery was performed in RYGB group, sham surgeries involved the same gastrointestinal transections as those in the RYGB group, and re-anastomosis was performed at the same sites. Fasting blood glucose levels and food intake were measured before and 1st, 2nd, 4th, 6th, 8th week after surgery. Oral glucose tolerance test (OGTT) and insulin tolerance test (ITT) were performed preoperatively and at 2nd and 8th week postoperatively. At 8th week postoperatively, the fasting serum bile acids levels were measured and hepatic tissues were taken to compare the mRNA expression of farnesoid X receptor (FXR), small heterodimeric partner (SHP), phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) by reverse transcriptase-polymerase chain reaction. Results:At 4th, 6th, 8th week postoperatively, the food intake in RYGB group [(18±2), (19±3), (20±4) g/d] was decreased as compared with sham surgery group [(24±3), (28±4), (26±3) g/d]; At 2nd, 4th, 6th and 8th week postoperatively, the fasting blood glucose levels in RYGB group [(6.9±0.9), (6.0±1.1), (6.4±0.8), (6.8±0.7) mmol/L] were decreased as compared with sham surgery group [(12.9±1.4), (10.8±0.8), (9.4±1.1), (9.0±1.0) mmol/L], with significant differences ( t=4.707, 5.091, 3.394, 9.209, 9.982, 6.239, 5.098, P<0.05); On postoperative week 2, the areas under the curve of OGTT and ITT in RYGB group [(898±118), (428±85) mmol/ (L·min)] were decreased compared with sham surgery group [(1 508±108), (788±98) mmol/ (L·min)]; On postoperative week 8, the areas under the curve of OGTT and ITT in RYGB group [(975±102), (455±76) mmol/ (L·min) ] were decreased as compared with sham surgery group [(1 575±96), (775±86) mmol/ (L·min) ], with significant differences ( t=10.790, 7.849, 12.120, 7.886, P<0.05); On postoperative week 8, the serum total bile acids level in RYGB group [(105.17±14.81) μmol/L] was increased as compared with sham surgery group [(68.87±10.81) μmol/L], with significant differences ( t=5.600, P<0.05); As compared with sham surgery group, the hepatic mRNA expression of FXR and SHP in RYGB group was up-regulated (1.67±0.31 vs. 1.17±0.11, 2.37±0.21 vs. 1.33±0.18), the hepatic mRNA expression of PEPCK and G6Pase in RYGB group was down-regulated (0.77±0.12 vs. 1.15±0.14, 0.87±0.08 vs. 1.05±0.10), with significant differences ( t=4.299, 10.640, 5.829, 3.976, P<0.05). Conclusion:RYGB can improve the glucose metabolism in T2DM rats, which may be related with increased hepatic bile acids signaling and decreased gluconeogenesis.